XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 32.31

+1.4%

Nov 26 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robert K. who wrote (7638)	11/4/1998 5:03:00 PM
From: Bluegreen	Read Replies (1) of 17367

Bob, for the sake of argument, who says insurance plans would have to pay for Neuprex usage in order for it to be a huge revenue bonanza? Now IF it really worked in dire emergency conditions and it was you or loved one in that circumstance, would you be willing to pay out of pocket? Are you saying only a few rich people would be willing to pay cost of Neuprex IF it works as being claimed by some researchers? What if you absolutely couldn't afford it? Would some churches, charities and other organizations be able to help? I can just see you now Bob with a gram neg. bacterial infection requiring IV antibiotics and you say "I don't won't to pay extra for that Neuprex."LOL All of this is moot though unless Neuprex actually works and is approved.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next